James R. Kasinger - 02 Dec 2021 Form 4 Insider Report for CRISPR Therapeutics AG (CRSP)

Role: General Counsel and Secretary
Signature: /s/ Michael Esposito, attorney-in-fact
Issuer symbol: CRSP
Transactions as of: 02 Dec 2021
Net transactions value: +$99,998
Form type: 4
Filing time: 03 Dec 2021, 19:00:16 UTC
Previous filing: 18 Oct 2021
Next filing: 07 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRSP	Common Shares	Options Exercise	$99,998	+7,342	+25%	$13.62	36,512	02 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRSP	Stock Option (Right to Buy)	Options Exercise	$0	-7,342	-7.3%	$0.000000	93,632	02 Dec 2021	Common Shares	7,342	$13.62	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on May 31, 2017 with respect to 123,000 Common Shares of which 25% vested on May 31, 2018 and the remaining 75% shall vest monthly thereafter for 36 months.